As Senior Director, Commercial Leader for the World Without Disease Accelerator (WWDA), Sue partners with Johnson & Johnson (J&J) Commercial teams across Sectors to create short- and long-range, end-to-end commercial strategies to help identify optimal pathways for value creation for WWDA initiatives.
Sue has more than 25 years of sales, marketing, and commercial strategy expertise across multiple therapeutic areas, including bone, immunology, type 1 diabetes, mood disorders, retina, and metabolism. Previously, Sue served as the Disease Area Stronghold Commercial Leader for Metabolism and Retina at Janssen. Before re-joining J&J in 2015 as Senior Director, External Innovation Strategy and Operations, Cardiovascular Metabolism, Sue held marketing and sales leadership roles at Neuronetics, Inc., Animas Corporation, Centocor, Procter & Gamble and IBM.
Sue has a Master of Business Administration from Cornell Johnson Graduate School of Management and a Bachelor of Science in Business Administration from Fordham University.